Dr. Peter Jay Van Veldhuizen Jr., MD

Dr. Van Veldhuizen practices at UM Health-West Hospital in Wyoming, Michigan.

Dr. Van Veldhuizen's NPI, 1336163138, was assigned on July 26, 2006. Dr. Van Veldhuizen graduated from Sanford School of Medicine of University of South Dakota in 1986. Dr. Van Veldhuizen holds Michigan license 4301510551.

Dr. Van Veldhuizen's primary practice is UM Health-West Hospital, at 5900 Byron Center SW Ave, Wyoming, MI 49519 in Kent County. The practice phone is (616) 252-7200.

Dr. Van Veldhuizen's primary practice is UM Health-West Hospital in Wyoming, Michigan. Dr. Van Veldhuizen is also affiliated with University of Michigan Health-West Hospital. The medical group on file is Trinity Health Medical Group. Dmand AI also links Dr. Van Veldhuizen to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Veldhuizen practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Van Veldhuizen's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Van Veldhuizen's licenses on file in 2 states: Michigan and New York.

CMS data shows 169 Medicare services from Dr. Van Veldhuizen across 3 procedure codes in 2024, all of them office visits, for 85 Medicare patients. Medicare paid $15,369 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 85 Medicare patients who saw Dr. Van Veldhuizen in 2024. The largest group is 65 to 74, with 44 patients. 66% of them have high blood pressure, and 62% have cancer. 16% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Van Veldhuizen's median patient age at 69, with 33% women.

In 2024, Dr. Van Veldhuizen wrote 542 Medicare Part D claims for 116 patients. 84% of them were for generic drugs. CMS names the drug for 413 of them, across 12 drugs with 11 or more claims each, at $1,208,774 in total drug cost. In 2023, CMS named 298 claims across 12 drugs.

Dr. Van Veldhuizen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 37 general payments to Dr. Van Veldhuizen from 11 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 86% of the total. Exelixis Inc. paid the most, $13,136.

Dr. Van Veldhuizen graduated from Sanford School of Medicine of University of South Dakota in 1986.